Recombinant CD19 (Inebilizumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, FACS
Host: Humanized
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CD19 (Inebilizumab Biosimilar) products
- CD19 (Inebilizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Humanized
-
Clonality
- Monoclonal
-
Conjugate
- This CD19 (Inebilizumab Biosimilar) antibody is un-conjugated
- Application
- ELISA, Flow Cytometry (FACS)
- Purpose
- Anti-CD19 (inebilizumab biosimilar) mAb
- Characteristics
- MEDI-551,Medi-551
- Purification
- Purified from cell culture supernatant by affinity chromatography
- Grade
- Research Grade
- Isotype
- IgG1
-
-
- Application Notes
- Flow Cyt 1:100
- Comment
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Expiry Date
- 12 months
-
- Target
- CD19 (Inebilizumab Biosimilar)
- Abstract
- CD19 (Inebilizumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- Synonyms: CD19,B4,CVID3,MGC12802
- Gene ID
- 930
- UniProt
- P15391
-
You are here:
